What an adult ICU resident needs when a sick child arrives: paediatric resuscitation and weight-based doses, sepsis and fluids, airway sizes and ventilation, bronchiolitis and croup, DKA, and safe transfer to a PICU — with worked doses for 10–20 kg children and Indian context.
6 topics
- 01
PALS and weight-based doses
Paediatric cardiac arrest (AHA/AAP 2025), bradycardia and SVT, weight estimation and the core resuscitation doses — with worked examples for a 10 kg and 20 kg child.
8 stepsAlgorithm6 dosesNew - 02
Paediatric sepsis and fluids
Phoenix sepsis criteria, the first-hour bundle from the Surviving Sepsis Campaign paediatric guideline, how much fluid to give (and when not to), vasoactive choice, maintenance fluids, and Indian special cases.
7 stepsAlgorithm5 dosesNew - 03
Paediatric airway: sizes, RSI and first ventilator settings
Endotracheal tube size and depth, laryngoscope blades and supraglottic airways by age/weight, a safe paediatric rapid sequence intubation, and lung-protective initial ventilation per PALICC-2.
8 stepsAlgorithm4 dosesNew - 04
Bronchiolitis and croup
Two common respiratory emergencies of infancy: bronchiolitis (supportive care, oxygen thresholds, HFNC/CPAP, what not to give) and croup (steroids for all, nebulised adrenaline for stridor at rest, and the dangerous mimics including diphtheria).
7 stepsAlgorithm3 dosesNew - 05
Paediatric diabetic ketoacidosis
ISPAD 2022-based management of DKA in children and adolescents: severity, cautious fluid deficit replacement over 24–48 h, insulin 0.05–0.1 unit/kg/h without bolus, potassium rules, the two-bag dextrose approach and recognising and treating cerebral oedema.
8 stepsAlgorithm5 dosesNew - 06
Safe transfer of a sick child to PICU
Stabilise-then-transfer: deciding when and how to move a critically ill child within or between hospitals, communication with the receiving PICU, team, equipment and oxygen planning, in-transit monitoring and handover — adapted to Indian ambulance realities.
9 stepsAlgorithm3 dosesNew
Drugs in this module
Doses written for this module's context. The same drug may read differently in another module.
Adrenaline (epinephrine) — paediatric
Catecholamine (alpha + beta agonist)
Adrenaline (epinephrine) — paediatric
Catecholamine (alpha + beta agonist)
- Indications
- Cardiac arrest; anaphylaxis; fluid-refractory (cold) septic shock; moderate–severe croup (nebulised); symptomatic bradycardia
- Adult dose
- Paediatric doses: arrest 0.01 mg/kg IV/IO (= 0.1 mL/kg of 0.1 mg/mL), max 1 mg, every 3–5 min. Anaphylaxis 0.01 mg/kg IM of 1 mg/mL (max 0.5 mg). Infusion 0.05–1 mcg/kg/min. Croup: nebulised 0.5 mL/kg of 1 mg/mL (max 5 mL).
- Preparation (India)
- 1 mg/mL (1:1000) 1 mL ampoules. Make 0.1 mg/mL by diluting 1 mL in 9 mL NS. Infusion e.g. 0.3 mg/kg in 50 mL: 1 mL/h = 0.1 mcg/kg/min.
- Cautions
- Confusing 1 mg/mL with 0.1 mg/mL causes 10-fold errors — label syringes. Extravasation risk if given peripherally undiluted.
- Monitoring
- ECG, BP, perfusion, lactate, glucose.
Amiodarone — paediatric
Class III antiarrhythmic
Amiodarone — paediatric
Class III antiarrhythmic
- Indications
- Shock-refractory VF/pulseless VT; perfusing wide-complex or refractory SVT (with expert advice)
- Adult dose
- Arrest: 5 mg/kg IV/IO bolus (max 300 mg), may repeat up to a total of 15 mg/kg. Perfusing tachycardia: 5 mg/kg over 20–60 min.
- Preparation (India)
- 150 mg/3 mL ampoule; dilute in D5W.
- Cautions
- Hypotension, bradycardia, QT prolongation; avoid combining with other QT-prolonging drugs without expert input.
- Monitoring
- ECG, BP.
Lidocaine (lignocaine) — paediatric
Class Ib antiarrhythmic
Lidocaine (lignocaine) — paediatric
Class Ib antiarrhythmic
- Indications
- Shock-refractory VF/pVT (alternative to amiodarone)
- Adult dose
- 1 mg/kg IV/IO bolus; infusion 20–50 mcg/kg/min.
- Preparation (India)
- 2% (20 mg/mL) preservative-free for IV use.
- Cautions
- Seizures and myocardial depression with toxicity.
- Monitoring
- ECG, neurological status.
Adenosine — paediatric
Purinergic AV-nodal blocker
Adenosine — paediatric
Purinergic AV-nodal blocker
- Indications
- SVT with a pulse after vagal manoeuvres
- Adult dose
- 0.1 mg/kg rapid IV push (max 6 mg) with immediate saline flush; second dose 0.2 mg/kg (max 12 mg).
- Preparation (India)
- 3 mg/mL, 2 mL vials.
- Cautions
- Give through a large proximal vein with a two-syringe/three-way-tap flush; transient asystole; bronchospasm in asthma.
- Monitoring
- Continuous ECG recording during the dose.
Atropine — paediatric
Antimuscarinic
Atropine — paediatric
Antimuscarinic
- Indications
- Bradycardia from increased vagal tone or primary AV block; selected intubations at risk of bradycardia
- Adult dose
- 0.02 mg/kg IV/IO (max single dose 0.5 mg); may repeat once.
- Preparation (India)
- 0.6 mg/mL ampoules.
- Cautions
- Not a substitute for oxygenation/ventilation in hypoxic bradycardia (commonest cause in children).
Dextrose 10% — paediatric
Carbohydrate
Dextrose 10% — paediatric
Carbohydrate
- Indications
- Hypoglycaemia in children (check glucose in every sick child)
- Adult dose
- 2–5 mL/kg of 10% dextrose IV/IO (0.2–0.5 g/kg); recheck glucose in 15–30 min; then maintenance dextrose.
- Preparation (India)
- 10% dextrose bags; to make from 25%: 2 parts 25% + 3 parts water/NS (approx. 10%).
- Cautions
- Avoid 25–50% dextrose peripherally in small children (vein injury); avoid hyperglycaemia.
Calcium chloride / calcium gluconate — paediatric
Electrolyte
Calcium chloride / calcium gluconate — paediatric
Electrolyte
- Indications
- Documented hypocalcaemia, hyperkalaemia, calcium-channel blocker toxicity (not routine in arrest)
- Adult dose
- Calcium chloride 10%: 20 mg/kg (0.2 mL/kg) IV/IO slowly (max 1 g). Calcium gluconate 10%: 60 mg/kg (0.6 mL/kg) IV/IO slowly (max 3 g).
- Preparation (India)
- Calcium gluconate 10% 10 mL ampoules are the usual Indian presentation; calcium chloride less widely stocked.
- Cautions
- Severe tissue injury if extravasated (especially chloride); not routine in cardiac arrest (2025 PALS).
Sodium bicarbonate — paediatric
Alkalinising agent
Sodium bicarbonate — paediatric
Alkalinising agent
- Indications
- Hyperkalaemia, sodium-channel blocker (TCA) toxicity; not routine in arrest
- Adult dose
- 1 mEq/kg slow IV/IO (8.4% = 1 mEq/mL; dilute 1:1 in infants).
- Cautions
- Not recommended routinely in paediatric arrest; flush line before catecholamines (inactivation).
Balanced crystalloid / 0.9% saline bolus — paediatric
IV fluid
Balanced crystalloid / 0.9% saline bolus — paediatric
IV fluid
- Indications
- Septic shock and hypovolaemia
- Adult dose
- 10–20 mL/kg over 5–20 min, reassess after each bolus; up to 40–60 mL/kg in the first hour where intensive care is available, stopping at signs of fluid overload (crackles, hepatomegaly, rising work of breathing). Balanced crystalloid (Ringer's lactate) suggested over 0.9% saline.
- Preparation (India)
- Ringer's lactate and 0.9% saline widely available; use 50 mL syringes 'push-pull' for small children.
- Cautions
- Without intensive care and without hypotension, SSC suggests no bolus (maintenance fluids instead). Severe acute malnutrition: use smaller, slower volumes (WHO).
- Monitoring
- HR, capillary refill, BP, liver span, crackles, urine output, lactate.
Noradrenaline (norepinephrine) — paediatric
Alpha-1 > beta-1 agonist
Noradrenaline (norepinephrine) — paediatric
Alpha-1 > beta-1 agonist
- Indications
- Warm (vasodilated) septic shock after fluids
- Adult dose
- 0.05–1 mcg/kg/min IV infusion, titrated to perfusion and age-appropriate MAP.
- Preparation (India)
- Common paediatric 'rule of 0.3': 0.3 mg/kg in 50 mL; 1 mL/h = 0.1 mcg/kg/min.
- Cautions
- May start through a good peripheral line in dilute form while central access is obtained (SSC).
Ceftriaxone — paediatric
Third-generation cephalosporin
Ceftriaxone — paediatric
Third-generation cephalosporin
- Indications
- Empirical antibiotic for community-acquired sepsis/meningitis beyond the neonatal period
- Adult dose
- Sepsis: 50–80 mg/kg IV once daily (max 2 g). Meningitis: 100 mg/kg/day IV in 1–2 doses (max 4 g/day). Give within 1 h of recognising septic shock.
- Preparation (India)
- 250 mg, 500 mg, 1 g vials.
- Cautions
- Avoid in neonates with hyperbilirubinaemia and with calcium-containing IV fluids in neonates.
Hydrocortisone — paediatric
Glucocorticoid
Hydrocortisone — paediatric
Glucocorticoid
- Indications
- Catecholamine-resistant septic shock with suspected adrenal insufficiency; known adrenal insufficiency/chronic steroid use
- Adult dose
- Commonly 2 mg/kg IV bolus (max 100 mg), then 1 mg/kg 6-hourly (max 50 mg/dose) or 50–100 mg/m²/day.
- Preparation (India)
- 100 mg vials.
- Cautions
- SSC suggests against routine use when fluids and vasopressors restore stability.
Ketamine — paediatric
NMDA antagonist (dissociative anaesthetic)
Ketamine — paediatric
NMDA antagonist (dissociative anaesthetic)
- Indications
- Induction for intubation in shocked or asthmatic children; procedural sedation
- Adult dose
- Induction 1–2 mg/kg IV (reduce to 0.5–1 mg/kg in profound shock); IM 4–5 mg/kg if no access.
- Preparation (India)
- 50 mg/mL vials (10 mL); dilute to 10 mg/mL for children.
- Cautions
- Laryngospasm and hypersalivation (rare); may still drop BP in catecholamine-depleted shock.
Rocuronium — paediatric
Non-depolarising neuromuscular blocker
Rocuronium — paediatric
Non-depolarising neuromuscular blocker
- Indications
- Rapid sequence intubation
- Adult dose
- 1–1.2 mg/kg IV.
- Preparation (India)
- 10 mg/mL (5 mL vials); refrigerate.
- Cautions
- Only after airway plan and failed-airway backup are ready; sugammadex availability varies.
Fentanyl — paediatric
Opioid analgesic
Fentanyl — paediatric
Opioid analgesic
- Indications
- Analgesia/blunting response at intubation; post-intubation analgesia
- Adult dose
- 1–2 mcg/kg IV slowly; infusion 1–4 mcg/kg/h.
- Preparation (India)
- 50 mcg/mL ampoules.
- Cautions
- Chest wall rigidity with rapid large doses (infants); hypotension; apnoea.
Dexamethasone (croup)
Glucocorticoid
Dexamethasone (croup)
Glucocorticoid
- Indications
- Croup (all severities)
- Adult dose
- 0.15–0.6 mg/kg PO (or IM/IV) single dose; 0.15 mg/kg is effective for mild–moderate croup; 0.6 mg/kg (max about 10–16 mg) often used for severe croup.
- Preparation (India)
- 0.5 mg tablets; 4 mg/mL injection can be given orally mixed in syrup.
- Cautions
- Single dose is usually enough.
Budesonide (nebulised)
Inhaled glucocorticoid
Budesonide (nebulised)
Inhaled glucocorticoid
- Indications
- Croup when oral route is not tolerated
- Adult dose
- 2 mg nebulised single dose.
- Preparation (India)
- 0.5 mg/2 mL respules (use 4 respules = 2 mg).
Regular (soluble) insulin — paediatric DKA
Insulin
Regular (soluble) insulin — paediatric DKA
Insulin
- Indications
- Paediatric DKA
- Adult dose
- 0.05–0.1 unit/kg/h IV infusion, started at least 1 h after starting fluid replacement; NO bolus.
- Preparation (India)
- 100 units/mL vials; 50 units in 50 mL NS = 1 unit/mL (prime the line).
- Cautions
- Hypokalaemia and hypoglycaemia; start only once K⁺ ≥3.5 mmol/L (ISPAD) or with K⁺ replacement running.
- Monitoring
- Hourly glucose, 2–4-hourly electrolytes/blood gas, hourly neuro observations.
Potassium chloride (in IV fluids) — paediatric DKA
Electrolyte
Potassium chloride (in IV fluids) — paediatric DKA
Electrolyte
- Indications
- Potassium replacement in DKA
- Adult dose
- Usually 40 mmol/L in rehydration fluid (20 mmol/L if fluid rate >10 mL/kg/h); start with initial volume expansion if hypokalaemic, with insulin if normokalaemic, and after urine output if hyperkalaemic. Keep within 0.5 mmol/kg/h.
- Preparation (India)
- 15% KCl = 2 mmol/mL (10 mL ampoule = 20 mmol); premixed bags preferred to avoid errors.
- Cautions
- Never give KCl as an IV bolus; mix bags thoroughly.
Mannitol — paediatric
Osmotic diuretic
Mannitol — paediatric
Osmotic diuretic
- Indications
- Cerebral oedema in DKA (or raised ICP)
- Adult dose
- 0.5–1 g/kg IV over 10–15 min; may repeat after 30 min if no response.
- Preparation (India)
- 20% mannitol (200 mg/mL): 0.5–1 g/kg = 2.5–5 mL/kg.
- Cautions
- Diuresis and hypovolaemia; crystallises if cold.
Hypertonic saline 3% — paediatric
Osmotic agent
Hypertonic saline 3% — paediatric
Osmotic agent
- Indications
- Cerebral oedema in DKA (alternative to mannitol)
- Adult dose
- 2.5–5 mL/kg of 3% NaCl IV over 10–15 min.
- Preparation (India)
- 3% NaCl bags available in most Indian hospitals; can be prepared from 0.9% saline + 15% or 23.4% NaCl per pharmacy protocol.
- Cautions
- Hypernatraemia, hyperchloraemic acidosis.
Module references (19)
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19

